Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP68211.RA3P2260KqmFlIrWas9762cq-OGQkMNTvi5b1s3VHBIls130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68211.RA3P2260KqmFlIrWas9762cq-OGQkMNTvi5b1s3VHBIls130_provenance.
• NP68213.RAmyxtp4fE_cStQyGAn2XDy8As1oCpdRzVGcjez5WZqRU130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68213.RAmyxtp4fE_cStQyGAn2XDy8As1oCpdRzVGcjez5WZqRU130_provenance.
• NP68529.RAE9DUM-dVfWQkNVDorfcP2SwpSURIwQ3Rud9sD1sLLkM130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68529.RAE9DUM-dVfWQkNVDorfcP2SwpSURIwQ3Rud9sD1sLLkM130_provenance.
• NP68541.RALIQAciqGbLKmy94FS5Wnsj7tACxnIhoYqNdWk7AWM6Y130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68541.RALIQAciqGbLKmy94FS5Wnsj7tACxnIhoYqNdWk7AWM6Y130_provenance.
• NP522676.RArTDfwBUSXGNG9YuQIzLmQlNG7qYljKnxAHAfFx29ylI130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522676.RArTDfwBUSXGNG9YuQIzLmQlNG7qYljKnxAHAfFx29ylI130_provenance.
• NP245317.RA0LzheDI80gHaJyq7nie9DnhrTUByk2MJSaHkfbrwZ-I130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245317.RA0LzheDI80gHaJyq7nie9DnhrTUByk2MJSaHkfbrwZ-I130_provenance.
• NP89278.RAcsAVU5Dl-pKuXphu4n2oqjXEdvNHm59BVNBCEJ9FK7E130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89278.RAcsAVU5Dl-pKuXphu4n2oqjXEdvNHm59BVNBCEJ9FK7E130_provenance.
• NP607937.RARJhcgOChe39foIGbRUTz1jvorTPq4OxJm7b_v4zx7Dw130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607937.RARJhcgOChe39foIGbRUTz1jvorTPq4OxJm7b_v4zx7Dw130_provenance.
• NP630384.RAbDQ-r4tRuoJzAAuKc82VoL7rS-XW1r_mgFtY5e-lQkI130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630384.RAbDQ-r4tRuoJzAAuKc82VoL7rS-XW1r_mgFtY5e-lQkI130_provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP137473.RAaFwYXeRxEWETbzQPif2kBdP7CeP0JtUKDXeS9oItEYM130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137473.RAaFwYXeRxEWETbzQPif2kBdP7CeP0JtUKDXeS9oItEYM130_provenance.
• NP64612.RAgvsHnJ8lQwb_Rhw8rry-jXIGgouhx9gAQBiKTW9vLOM130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64612.RAgvsHnJ8lQwb_Rhw8rry-jXIGgouhx9gAQBiKTW9vLOM130_provenance.
• NP711792.RAaQJDUQLu9jLLF8P_gAh7tUwWBqXxH-VYLDue52GJzvE130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711792.RAaQJDUQLu9jLLF8P_gAh7tUwWBqXxH-VYLDue52GJzvE130_provenance.
• NP607971.RAnlCxAFRNJODRfed9imq-HGMKmr-gsml8uSB_sZyY-MU130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607971.RAnlCxAFRNJODRfed9imq-HGMKmr-gsml8uSB_sZyY-MU130_provenance.
• NP630509.RAs1xzNc8WzneWPaBQiWgx4YhMjtZ7ABC-nn0cK27tHVs130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630509.RAs1xzNc8WzneWPaBQiWgx4YhMjtZ7ABC-nn0cK27tHVs130_provenance.
• NP711787.RApYGQqPexpC3krL3VfAkLH9CyfwPDQ3KrByY51Y2tDCE130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711787.RApYGQqPexpC3krL3VfAkLH9CyfwPDQ3KrByY51Y2tDCE130_provenance.
• NP607366.RAzZj52mnt2Sp6PkFS5CaU8YMd_qxw5HMln76G5deylfU130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607366.RAzZj52mnt2Sp6PkFS5CaU8YMd_qxw5HMln76G5deylfU130_provenance.
• NP607562.RAzTcM4PiwEvmA_6FxqvbzSqB0ea4DqGEVhRjRKMubsPU130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607562.RAzTcM4PiwEvmA_6FxqvbzSqB0ea4DqGEVhRjRKMubsPU130_provenance.
• NP137474.RAI9rWqCqknbF08YBMvPTkAxbyDpPJXzMhChq5Oh3IU6w130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137474.RAI9rWqCqknbF08YBMvPTkAxbyDpPJXzMhChq5Oh3IU6w130_provenance.
• NP711783.RA4DD9fNXYXefdjvkm8Tzn_BVeQWLx8OL7QO0XW5zikU0130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711783.RA4DD9fNXYXefdjvkm8Tzn_BVeQWLx8OL7QO0XW5zikU0130_provenance.
• NP711784.RA-eO5jZH1b8o3JfcoPaElhurMAmhan9Xux5ukR9DPYKM130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711784.RA-eO5jZH1b8o3JfcoPaElhurMAmhan9Xux5ukR9DPYKM130_provenance.
• NP711785.RA1lBtnOwZhMzwRy4qaXt_vmKhnzxobI_jC06QA3hOO0o130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711785.RA1lBtnOwZhMzwRy4qaXt_vmKhnzxobI_jC06QA3hOO0o130_provenance.
• NP711791.RAykkZsgLRLc6FCzDBXBJcvNPTcUzl5eapgPPMKge5nSU130_assertion description "[Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711791.RAykkZsgLRLc6FCzDBXBJcvNPTcUzl5eapgPPMKge5nSU130_provenance.